Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03015129 |
|---|---|
| Brief Title: | A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer |
| First Submitted : | January 4, 2017 |
| First Submitted that Met QC Criteria : | January 6, 2017 |
| First Posted : | January 9, 2017 (Estimate) |
| Results First Submitted : | December 6, 2023 |
| Results First Submitted that Met QC Criteria : | January 12, 2024 |
| Results First Posted : | February 6, 2024 |
| Last Update Submitted that Met QC Criteria : | January 12, 2024 |
| Last Update Posted : | February 6, 2024 |